Seems that way, what is the reason(s), do you think?

Frrol, I do appreciate your posts, you are a good counterbalance but these petty attacks are not a good look on you and diminish any creditably you have.

Best wishes, Investor!

Please don’t let this shake the foundation of your faith in Santa Claus nor Dr. Middling.

Keep up the good fight!

Anyone found last weeks presentation yet?

Veritas vincit!

Sometimes I wish they would fall off.
I have a brother in Norway, I am always looking for a chance to have a visit.

How different are Danes from Germans? Do you consider Danes Scandinavians? I heard those fins are a crazy bunch

What is your confidence level in Anavex management?
Why do you stay invested, I assume you are not a sucker for punishment.

Thanks
Why do you think Anavex has left the Corp presentations with the timeframe as 2H 2021?

Can you remind us about why you think Feb is the time frame? Is it mostly because of Anavex’s past track record analyzing and releasing data?

Oh, I am well aware, I used to ignore and thought he may go away but alas…. So now I am going to try other tactics, gotta have fun somehow

When should I sell, can you help me?

I feel much warmer and fuzzier as a result of the tweet anyways, who needs data?!

I like what you are thinking, JJ. But I am not going to let my semi-educated hope get the best of me!

The world is well again

Thank you, Investor!

Please remind us of the other conference/pr situation you allude to.

I’ve missed you, where have you been?

Let’s say, hypothetically, the Avatar data is excellent, what would the impact on share price be and how would the hypothetically excellent data impact application for FDA approval?

What’s better semi educated guesses or semi educated hopes?
I am still wondering about OLE PDD data, will that be released/PR’d? Why, when, under what circumstances?

Do you have a date associated with that PPS prediction?

We love our whiskey

Under what circumstances or when would the ole PDD data be released?

Thank you for the education!

Thanks George. Isn’t there a conference next week as well?

My new fav word “soon”, especially emphatic, underlined “soons”

Yes, thank you, my error. Question still stands please switch Excellence to Avatar?

Hypothetically, if TGD wanted to share Excellence trial data at the conference next week, when would the PR come out?

The day of or the day prior? Or even the week before to prepare the audience/market?

Perfect, appreciate it, Mystic!

Thanks, Mystic
Forgive my ignorance, what are the “P” points?

I like this better than the recent predictions, do you have a chart to support? Thanks

However, I did miss Tom Bishop this time around

Thanks, George and Plex!

Having Kornhauser join the company is very telling….. I hope

I thought this was to be the catalyst rich quarter, the 2nd Q was to be the data rich one. Either way, disappointing

And why so early this year? Last years Q4 earnings call was in late December

Government agencies are investigating $SAVA, as its experimental, hyped-up Alzheimer's drug faces scrutiny https://t.co/gldxgQCqR6

— Andrew Dunn (@AndrewE_Dunn) November 16, 2021

Any chance the new FDA head will want to make a “splash” shortly after taking office?